公开(公告)号：AU2016351308C1

公开(公告)日：2022-02-24

申请号：AU2016351308

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFβ1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine or joint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：MA43181A

公开(公告)日：2018-09-12

申请号：MA43181

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: A61K31/7008 ,  A61K9/08 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08B37/08

公开(公告)号：PE12942018A1

公开(公告)日：2018-08-07

申请号：PE0007352018

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: A61K38/18 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08B37/08

CPC classification number: A61K31/737 ,  A61K9/0019 ,  A61K9/08 ,  A61K31/7008 ,  A61K38/1841 ,  A61K47/20 ,  A61K47/26 ,  A61K47/36 ,  A61K47/38 ,  A61P19/02 ,  C07H3/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08L1/286 ,  C08L5/08

Abstract: Se refiere a una composicion que comprende sulfato de condroitina de 0.1% a 2 % en peso, clorhidrato de glucosamina de 1% a 25% en peso, factor de crecimiento de tejido conjuntivo de 50 ng/mg a 500 ng/mg, factor de crecimiento transformante beta 1 de 10 ng/mg a 100ng/mg y una solucion acuosa que comprende agua, solucion amortiguadora y/o sulfoxido de dimetilo. Dicha composicion es util en el tratamiento o prevencion de una enfermedad discal degenerativa, lesion de disco, dolor, entre otras

公开(公告)号：CA3000757A1

公开(公告)日：2017-05-11

申请号：CA3000757

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: A61K38/18 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFß1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine or joint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.